The goal of this registry database is to demonstrate the safety and effectiveness of functional ventricular tachycardia (VT) ablation using SENSE protocol in patients with ischaemic VT. Mortality and the need for ICD therapies at 12 months post-ablation will be compared with propensity-matched controls undergoing substrate-based ablation alone.
This is an international multicentre prospective registry. Participating centres will collect data during the pre-assessment, procedure, and follow-up visits at 6 and 12 months, according to standard practice. It is anticipated that the enrolment duration will be approximately 12 months, with the data being matched with that collected from a control group of patients undergoing conventional Ventricular tachycardia ablation methods.
Study Type
OBSERVATIONAL
Enrollment
70
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
RECRUITINGOnassis Cardiac Surgery Center
Athens, Greece
RECRUITINGVirgen de las Nieves University Hospital
Granada, Spain
Composite of cardiovascular mortality and ICD therapy
Composite of cardiovascular mortality and implantable cardioverter-defibrillator (ICD) therapy
Time frame: 12 months
Length of hospital stay
Length of hospital stay
Time frame: 1 month
Left ventricular function on echocardiogram
Left ventricular function on echocardiogram
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Arrhythmia Unit, University Hospital Ramón y Cajal
Madrid, Spain
RECRUITINGBasildon University Hospital
Basildon, United Kingdom
RECRUITINGRoyal Sussex County Hospital
Brighton, United Kingdom
RECRUITINGRoyal Brompton & Harefield hospital
London, United Kingdom
RECRUITINGSt Bartholomew's Hospital
London, United Kingdom
RECRUITING